Evaluation of oral antimicrobial agent levels in tooth extraction sites

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 91, Issue 6, 2001, Pages 643-648

  Yoshii, Takashi ^a,b   Yoshikawa, Tomohiro ^a   Furudoi, Shungo ^a   Yoshioka, Ayumi ^a   Ohtsuka, Yoshiki ^a   Komori, Takahide ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Dentistry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFACLOR; CEFDINIR; CEFMENOXIME; CEFTERAM PIVOXIL; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; DRUG DERIVATIVE; OFLOXACIN; PENICILLIN DERIVATIVE; PRODRUG; TALAMPICILLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; HUMAN; JAW; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; TIME; TOOTH DISEASE; TOOTH EXTRACTION; TOOTH SOCKET;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALVEOLAR PROCESS; ANTI-BACTERIAL AGENTS; CEFACLOR; CEFMENOXIME; CEFUROXIME; CEPHALOSPORINS; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PENICILLINS; PRODRUGS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCUS; TALAMPICILLIN; TIME FACTORS; TOOTH DISEASES; TOOTH EXTRACTION; TOOTH SOCKET;

EID: 0035378311     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.114383     Document Type: Article

References (23)

1. Monaco G, Staffolani C, Gatto MR, Checchi L. Antibiotic therapy in impacted third molar surgery. Eur J Oral Sci 1999; 107:437-41.
2. Zeitler DL. Prophylactic antibiotics for third molar surgery: a dissenting opinion. J Oral Maxillofac Surg 1995;53:61-4.
3. Piecuch JF, Arzadon J, Lieblich SE. Prophylactic antibiotics for third molar surgery: a suportive opinion. J Oral Maxillofac Surg 1995;53:53-60.
4. Peterson LJ. Antibiotic prophylaxis against wound infections in oral and maxillofacial surgery. J Oral Maxillofac Surg 1990;48: 617-20.
5. Oikarinen VJ, Malmstrom M. Penicillin V concentration in dental alveolar blood after tooth extraction. Scand J Dent Res 1972;80:279-84.
6. Bystedt H, Dahlback A, Nord CE. Concentration of azidocillin, erythromycin, doxycycline and clindamycin in dental alveolar serum after single oral doses. Int J Oral Surg 1977;6:65-74.
7. Bystedt H, Konow LV, Nord CE. A comparison of the effect of phenoximethylpenicillin and azidocillin on postoperative complications after surgical removal of impacted mandibular third molars. Swed Dent J 1981;5:225-34.
8. Kondell PA, Nord CE, Nordenram A. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone. Int J Oral Surg 1982;11:40-3.
9. Yamamoto H, Ishibashi K, Sasaki J, Morishima T, Michi K, Mori K, et al. Cefpodoxime proxetil (CPDX-PR) into tooth extraction wound and oral tissues. Oral Therap Pharmacol 1993; 12:39-45.
10. Morishima T, Wada N, MiyachiI S, Sekino Y, Sasaki J, Kouno M. Blood level of exodontia wound after oral administration of Lenampicillin (LAPC). Oral Ther Pharmacol 1989;8:127-35.
11. Toyoura T, Morishima T. Blood level of exodontia wound after oral administration of Sparfloxacin (AT 4140). Oral Therap Pharmacol 1991;10:91-6.
12. Morishima T, Sakamoto H, Sasaki J, Shimosato T, Nomura M, Ishibashi K, et al. NY-198 in oral and maxillofacial infections. Jpn J Chemother 1988;36(suppl 2):1388-401.
13. Sasaki J, Kaneko A, Shiiki K, Sugano K, Sakamoto H, Satoh T, et al. Comparative clinical study of Cefteram pivoxil (CFTM-PI) with Cefaclor (CCL) in the treatment of odontogenic infections. Oral Therap Pharmacol 1991;10:20-41.
14. Sasaki J, Gotoh J, Morihana K, Uematsu M, Takai H, Ohmura H, et al. A comparative double blind study of lenanpicillin and talampicillin in the treatment of oral infections. Jpn J Antibiot 1985;38:2453-80.
15. Sasaki J, Morihana T, Kaneko A, Michi K, Takahashi K, Fukuoka F, et al. Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs cefaclor. Jpn J Antibiot 1990;43:2035-68.
16. Sasaki J, Uematsu M, Sakamoto H, Takai H, Ikeshima K, Ozaki H, et al. Comparative clinical study of ofloxacin (OFLX) with talampicillin hydrochloride (TAPC) in the treatment of oral infections. Oral Therap Pharmacol 1987;6:45-61.
17. Sasaki J, Uematsu M, Takai H, Ikeshima K, Ohne M, Yoshida T, et al. Basic and clinical studies on cefdinir in dentistry and oral surgery. Oral Therap Pharmacol 1992;11:68-85.
18. Aderhold L, Knothe H, Frenkel G. The bacteriology of odontogenous pyogenic infections. Oral Surg Oral Med Oral Pathol 1981;52:583-7.
19. Kaneko A, Sasaki J. Study of causative organisms from the closed abscess and their MICs in the cases of odontogenic infections. Oral Therap Pharmacol 1993;12:55-66.
20. Sasaki J, Kaneko A, Yazaki J, Kobayashi I. Classification of 1145 strains of odontogenic infection-causing organisms identified from March 1993 to December 1995. Oral Therap Pharmacol 1997;16:82-5.
21. Kaneko A, Sasaki J. MICs of 407 oral streptococci strains isolated from closed abscess of odontogenic infection. Jpn J Chemother 1993;41:1049-55.
22. Nanba R, Taguchi M, Tsuto H, Minami Y, Yamamoto T, Nakao K, et al Fundamental and clinical studies on cefaclor in the field of oral surgery. Oral Therap Pharmacol 1983;2:79-93.
23. Sano A, Ohtsuka Y, Hirano F, Motoji S, Nakasuji K, Ichii M, et al. Bone tissue concentration of ofloxacin. Chemotherapy 1991; 39:976-81.